SEATTLE (AP) _ Omeros Corporation (OMER) on Tuesday reported a loss of $14.4 million in its second quarter.
The Seattle-based company said it had a loss of 33 cents per share. Losses, adjusted for non-recurring costs, were 23 cents per share.
The drug developer posted revenue of $17.2 million in the period.
Omeros shares have more than doubled since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $21.72, a climb of 74 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OMER at https://www.zacks.com/ap/OMER
Keywords: Omeros, Earnings Report